SNU-2708.1
| KCLB NO |
02708.1
|
|---|---|
| Name |
SNU-2708.1
|
세포주 분양조건
서비스
수량
-
+
| Origin |
lung
|
|---|---|
| Species |
human, asian male, 56 years old
|
| Cellular morphology |
floating
|
| Growth Pattern |
round
|
| Histopathology |
adenocarcinoma
|
| Depositor |
Ja-Lok Ku
|
| Option |
culture only
|
| D3S1358 |
18
|
|---|---|
| vWA |
17
|
| FGA |
20,23
|
| Amelogenin |
X,Y
|
| TH01 |
9
|
| TPOX |
9
|
| CSF1P0 |
10,11
|
| D5S818 |
11
|
| D13S317 |
11
|
| D7S820 |
8,10
|
준비중입니다.
| freeze media |
RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%
|
|---|---|
| original medium |
RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%
|
| kclb media |
RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%
|
| subculturing |
Collect the cells into 15ml tube and centrifue, aspirate the culture medium, resuspend the pellets, dispense the cells into the culture flask
|
| media change |
Collect the cells and centrifuge, remove two thirds of medium, add fresh medium (depending on cell density) every 2 to 3 days
|
|
Culture and multiomic analysis of lung cancer patient‑derived pleural efusions revealed distinct druggable molecular types, Sci Rep. 2022 Apr 15;12(1):6345.
|
|---|
